氯吡格雷 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "氯吡格雷" in Chinese language version.

refsWebsite

Global rank Chinese rank

19nih.gov

4^th place

5^th place

17web.archive.org

1^st place

17doi.org

2^nd place

23^rd place

6semanticscholar.org

11^th place

332^nd place

4drugs.com

399^th place

208^th place

3europa.eu

68^th place

209^th place

3fda.gov

447^th place

581^st place

2clincalc.com

3,912^th place

5,917^th place

2imshealth.com

low place

1lexico.com

1,242^nd place

3,795^th place

1medicines.org.uk

3,823^rd place

3,456^th place

1books.google.com

3^rd place

8^th place

1handle.net

102^nd place

492^nd place

1webmd.com

1,169^th place

1,094^th place

1drugpatentwatch.com

low place

1prnewswire.com

406^th place

918^th place

1ducknetweb.blogspot.com

low place

books.google.com

Fischer J, Ganellin CR. Analogue-based Drug Discovery. John Wiley & Sons. 2006: 453. ISBN 9783527607495. （原始内容存档于20 December 2016）.

clincalc.com

The Top 300 of 2022. ClinCalc. [2024-08-30]. （原始内容存档于2024-08-30）.
Clopidogrel Drug Usage Statistics, United States, 2013 - 2022. ClinCalc. [2024-08-30].

doi.org

O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. January 2013, 61 (4): e78–140. PMID 23256914. doi:10.1016/j.jacc.2012.11.019 .
Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. August 2012, 126 (7): 875–910. PMID 22800849. doi:10.1161/CIR.0b013e318256f1e0 .
Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR, Smith SC, Spertus JA, Williams SV. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. December 2012, 126 (25): 3097–137. PMID 23166210. doi:10.1161/CIR.0b013e3182776f83 .
Gagne JJ, Bykov K, Choudhry NK, Toomey TJ, Connolly JG, Avorn J. Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison.. BMJ (Clinical Research Ed.) //www.ncbi.nlm.nih.gov/pmc/articles/PMC3775704 |PMC=缺少标题 (帮助). 2013-09-17, 347: f5307. PMC 3775704 . PMID 24046285. doi:10.1136/bmj.f5307 .
Zakarija A, Bandarenko N, Pandey DK, Auerbach A, Raisch DW, Kim B, Kwaan HC, McKoy JM, Schmitt BP, Davidson CJ, Yarnold PR, Gorelick PB, Bennett CL. Clopidogrel-Associated TTP An Update of Pharmacovigilance Efforts Conducted by Independent Researchers, Pharmaceutical Suppliers, and the Food and Drug Administration. Stroke. 2004, 35 (2): 533–8. PMID 14707231. doi:10.1161/01.STR.0000109253.66918.5E .
Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. The Lancet. 2004, 364 (9431): 331–7. PMID 15276392. S2CID 9874277. doi:10.1016/S0140-6736(04)16721-4.
Farhat N, Haddad N, Crispo J, Birkett N, McNair D, Momoli F, Wen SW, Mattison DR, Krewski D. Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000-2016. Eur. J. Clin. Pharmacol. February 2019, 75 (2): 227–235. PMID 30324301. S2CID 53085923. doi:10.1007/s00228-018-2564-8.
Wedemeyer RS, Blume H. Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update. Drug Safety. 2014, 37 (4): 201–11. PMC 3975086 . PMID 24550106. doi:10.1007/s40264-014-0144-0.
John J, Koshy SK. Current Oral Antiplatelets: Focus Update on Prasugrel. The Journal of the American Board of Family Medicine. 2012, 25 (3): 343–349. PMID 22570398. doi:10.3122/jabfm.2012.03.100270 .
Cattaneo M. Response variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution?. Journal of Thrombosis and Haemostasis. March 2012, 10 (3): 327–36. PMID 22221409. S2CID 34477003. doi:10.1111/j.1538-7836.2011.04602.x .
Pereillo JM, Maftouh M, Andrieu A, Uzabiaga MF, Fedeli O, Savi P, Pascal M, Herbert JM, Maffrand JP, Picard C. Structure and stereochemistry of the active metabolite of clopidogrel. Drug Metab. Dispos. 2002, 30 (11): 1288–95. PMID 12386137. S2CID 2493588. doi:10.1124/dmd.30.11.1288.
Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, Sabatine MS. Cytochrome p-450 polymorphisms and response to clopidogrel. The New England Journal of Medicine. January 2009, 360 (4): 354–62. PMID 19106084. doi:10.1056/NEJMoa0809171 .
Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, Steg PG, Ferrières J, Danchin N, ((Becquemont L, French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators)). Genetic Determinants of Response to Clopidogrel and Cardiovascular Events. The New England Journal of Medicine. January 2009, 360 (4): 363–75. PMID 19106083. doi:10.1056/NEJMoa0808227 . 温哥华格式错误 (帮助)
Collet JP, Hulot JS, Pena A, Villard E, Esteve JB, Silvain J, Payot L, Brugier D, Cayla G, Beygui F, Bensimon G, Funck-Brentano C, Montalescot G. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. The Lancet. January 2009, 373 (9660): 309–17. PMID 19108880. S2CID 22405890. doi:10.1016/S0140-6736(08)61845-0.
Patel, Amisha; Vidula, Mahesh. Circulation-Cardiovascular Quality and Outcomes https://pmc.ncbi.nlm.nih.gov/articles/PMC4512846/. 2015-06-02, 8 (4): 447–451 [2025-01-17]. doi:10.1161/CIRCOUTCOMES.115.001866. 缺少或|title=为空 (帮助)
Topol EJ, Schork NJ. Catapulting clopidogrel pharmacogenomics forward. Nature Medicine. January 2011, 17 (1): 40–41. PMID 21217678. S2CID 32083067. doi:10.1038/nm0111-40.
Hogan DF, Andrews DA, Green HW, Talbott KK, Ward MP, Calloway BM. Antiplatelet effects and pharmacodynamics of clopidogrel in cats. J Am Vet Med Assoc. 2004, 225 (9): 1406–1411. PMID 15552317. doi:10.2460/javma.2004.225.1406 .

drugpatentwatch.com

Details for Plavix. （原始内容存档于2014-08-14）.

drugs.com

Clopidogrel International brand names. Drugs.com. [2017-04-01]. （原始内容存档于2017-04-01）.
Clopidogrel (Plavix) Use During Pregnancy. Drugs.com. [14 December 2016]. （原始内容存档于21 December 2016）.
Clopidogrel Bisulfate. The American Society of Health-System Pharmacists. [2016-12-08]. （原始内容存档于2016-12-21）.
Clopidogrel Multum消费者信息

ducknetweb.blogspot.com

FDA Gives Plavix a 6 Month Extension-Patent Now Expires on 17 May 2012. 26 January 2011 [2012-01-12]. （原始内容存档于2011-10-12）.

europa.eu

ema.europa.eu

Plavix EPAR. European Medicines Agency (EMA). 1998-07-14 [2024-01-15].
Iscover EPAR. European Medicines Agency (EMA). 1998-01-14 [2024-08-15].
DuoPlavin EPAR. European Medicines Agency (EMA). 2018-09-17 [2020-08-21]. （原始内容存档于2020-09-04）.

fda.gov

Public Health Advisory: Updated Safety Information about a drug interaction between Clopidogrel Bisulfate (marketed as Plavix) and Omeprazole (marketed as Prilosec and Prilosec OTC). Food and Drug Administration (FDA). 2009-11-17 [2010-03-13]. （原始内容存档于2009-12-29）.
Safety announcement: Reduced effectiveness of Plavix in patients who are poor metabolizers. U.S. Food and Drug Administration. 3 August 2017. （原始内容存档于2010-03-15）.
FDA approves generic versions of blood thinner Plavix (新闻稿). U.S. Food and Drug Administration (FDA). 2012-05-17. （原始内容存档于2016-03-11）.

handle.net

hdl.handle.net

World Health Organization. The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. 2023. hdl:10665/371090 . WHO/MHP/HPS/EML/2023.02.

imshealth.com

www1.imshealth.com

New products and markets fuel growth in 2005. IMS Health. [2009-03-02]. （原始内容存档于2008-06-03）.

imshealth.com

Top Ten Global Products – 2007 (PDF). IMS Health. 26 February 2008 [2009-03-02]. （原始内容存档 (PDF)于2011-02-25）.

lexico.com

Clopidogrel. Lexico Dictionaries. [2019-10-26]. （原始内容存档于2019-10-25）.

medicines.org.uk

Plavix Summary of Product Characteristics (SmPC). (emc). 2023-01-23 [2024-01-15].

nih.gov

ncbi.nlm.nih.gov

O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. January 2013, 61 (4): e78–140. PMID 23256914. doi:10.1016/j.jacc.2012.11.019 .
Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. August 2012, 126 (7): 875–910. PMID 22800849. doi:10.1161/CIR.0b013e318256f1e0 .
Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR, Smith SC, Spertus JA, Williams SV. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. December 2012, 126 (25): 3097–137. PMID 23166210. doi:10.1161/CIR.0b013e3182776f83 .
Gagne JJ, Bykov K, Choudhry NK, Toomey TJ, Connolly JG, Avorn J. Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison.. BMJ (Clinical Research Ed.) //www.ncbi.nlm.nih.gov/pmc/articles/PMC3775704 |PMC=缺少标题 (帮助). 2013-09-17, 347: f5307. PMC 3775704 . PMID 24046285. doi:10.1136/bmj.f5307 .
Zakarija A, Bandarenko N, Pandey DK, Auerbach A, Raisch DW, Kim B, Kwaan HC, McKoy JM, Schmitt BP, Davidson CJ, Yarnold PR, Gorelick PB, Bennett CL. Clopidogrel-Associated TTP An Update of Pharmacovigilance Efforts Conducted by Independent Researchers, Pharmaceutical Suppliers, and the Food and Drug Administration. Stroke. 2004, 35 (2): 533–8. PMID 14707231. doi:10.1161/01.STR.0000109253.66918.5E .
Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. The Lancet. 2004, 364 (9431): 331–7. PMID 15276392. S2CID 9874277. doi:10.1016/S0140-6736(04)16721-4.
Farhat N, Haddad N, Crispo J, Birkett N, McNair D, Momoli F, Wen SW, Mattison DR, Krewski D. Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000-2016. Eur. J. Clin. Pharmacol. February 2019, 75 (2): 227–235. PMID 30324301. S2CID 53085923. doi:10.1007/s00228-018-2564-8.
Wedemeyer RS, Blume H. Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update. Drug Safety. 2014, 37 (4): 201–11. PMC 3975086 . PMID 24550106. doi:10.1007/s40264-014-0144-0.
John J, Koshy SK. Current Oral Antiplatelets: Focus Update on Prasugrel. The Journal of the American Board of Family Medicine. 2012, 25 (3): 343–349. PMID 22570398. doi:10.3122/jabfm.2012.03.100270 .
Cattaneo M. Response variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution?. Journal of Thrombosis and Haemostasis. March 2012, 10 (3): 327–36. PMID 22221409. S2CID 34477003. doi:10.1111/j.1538-7836.2011.04602.x .
Pereillo JM, Maftouh M, Andrieu A, Uzabiaga MF, Fedeli O, Savi P, Pascal M, Herbert JM, Maffrand JP, Picard C. Structure and stereochemistry of the active metabolite of clopidogrel. Drug Metab. Dispos. 2002, 30 (11): 1288–95. PMID 12386137. S2CID 2493588. doi:10.1124/dmd.30.11.1288.
Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, Sabatine MS. Cytochrome p-450 polymorphisms and response to clopidogrel. The New England Journal of Medicine. January 2009, 360 (4): 354–62. PMID 19106084. doi:10.1056/NEJMoa0809171 .
Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, Steg PG, Ferrières J, Danchin N, ((Becquemont L, French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators)). Genetic Determinants of Response to Clopidogrel and Cardiovascular Events. The New England Journal of Medicine. January 2009, 360 (4): 363–75. PMID 19106083. doi:10.1056/NEJMoa0808227 . 温哥华格式错误 (帮助)
Collet JP, Hulot JS, Pena A, Villard E, Esteve JB, Silvain J, Payot L, Brugier D, Cayla G, Beygui F, Bensimon G, Funck-Brentano C, Montalescot G. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. The Lancet. January 2009, 373 (9660): 309–17. PMID 19108880. S2CID 22405890. doi:10.1016/S0140-6736(08)61845-0.
Topol EJ, Schork NJ. Catapulting clopidogrel pharmacogenomics forward. Nature Medicine. January 2011, 17 (1): 40–41. PMID 21217678. S2CID 32083067. doi:10.1038/nm0111-40.
Hogan DF, Andrews DA, Green HW, Talbott KK, Ward MP, Calloway BM. Antiplatelet effects and pharmacodynamics of clopidogrel in cats. J Am Vet Med Assoc. 2004, 225 (9): 1406–1411. PMID 15552317. doi:10.2460/javma.2004.225.1406 .

dailymed.nlm.nih.gov

Plavix- clopidogrel bisulfate tablet, film coated. DailyMed. Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. 2019-05-17 [2019-12-26]. （原始内容存档于2020-08-04）.
Plavix- clopidogrel tablet, film coated. DailyMed. 2022-09-22 [2024-01-15].

pmc.ncbi.nlm.nih.gov

Patel, Amisha; Vidula, Mahesh. Circulation-Cardiovascular Quality and Outcomes https://pmc.ncbi.nlm.nih.gov/articles/PMC4512846/. 2015-06-02, 8 (4): 447–451 [2025-01-17]. doi:10.1161/CIRCOUTCOMES.115.001866. 缺少或|title=为空 (帮助)

prnewswire.com

Preliminary Injunction Against Apotex Upheld on Appeal (新闻稿). Bristol-Myers Squibb. 2006-12-08 [2010-03-14]. （原始内容存档于2014-04-14）.

semanticscholar.org

api.semanticscholar.org

Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. The Lancet. 2004, 364 (9431): 331–7. PMID 15276392. S2CID 9874277. doi:10.1016/S0140-6736(04)16721-4.
Farhat N, Haddad N, Crispo J, Birkett N, McNair D, Momoli F, Wen SW, Mattison DR, Krewski D. Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000-2016. Eur. J. Clin. Pharmacol. February 2019, 75 (2): 227–235. PMID 30324301. S2CID 53085923. doi:10.1007/s00228-018-2564-8.
Cattaneo M. Response variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution?. Journal of Thrombosis and Haemostasis. March 2012, 10 (3): 327–36. PMID 22221409. S2CID 34477003. doi:10.1111/j.1538-7836.2011.04602.x .
Pereillo JM, Maftouh M, Andrieu A, Uzabiaga MF, Fedeli O, Savi P, Pascal M, Herbert JM, Maffrand JP, Picard C. Structure and stereochemistry of the active metabolite of clopidogrel. Drug Metab. Dispos. 2002, 30 (11): 1288–95. PMID 12386137. S2CID 2493588. doi:10.1124/dmd.30.11.1288.
Collet JP, Hulot JS, Pena A, Villard E, Esteve JB, Silvain J, Payot L, Brugier D, Cayla G, Beygui F, Bensimon G, Funck-Brentano C, Montalescot G. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. The Lancet. January 2009, 373 (9660): 309–17. PMID 19108880. S2CID 22405890. doi:10.1016/S0140-6736(08)61845-0.
Topol EJ, Schork NJ. Catapulting clopidogrel pharmacogenomics forward. Nature Medicine. January 2011, 17 (1): 40–41. PMID 21217678. S2CID 32083067. doi:10.1038/nm0111-40.

web.archive.org

Clopidogrel. Lexico Dictionaries. [2019-10-26]. （原始内容存档于2019-10-25）.
Clopidogrel International brand names. Drugs.com. [2017-04-01]. （原始内容存档于2017-04-01）.
Clopidogrel (Plavix) Use During Pregnancy. Drugs.com. [14 December 2016]. （原始内容存档于21 December 2016）.
Plavix- clopidogrel bisulfate tablet, film coated. DailyMed. Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. 2019-05-17 [2019-12-26]. （原始内容存档于2020-08-04）.
Clopidogrel Bisulfate. The American Society of Health-System Pharmacists. [2016-12-08]. （原始内容存档于2016-12-21）.
Fischer J, Ganellin CR. Analogue-based Drug Discovery. John Wiley & Sons. 2006: 453. ISBN 9783527607495. （原始内容存档于20 December 2016）.
The Top 300 of 2022. ClinCalc. [2024-08-30]. （原始内容存档于2024-08-30）.
DuoPlavin EPAR. European Medicines Agency (EMA). 2018-09-17 [2020-08-21]. （原始内容存档于2020-09-04）.
DeNoon DJ. FDA Warns Plavix Patients of Drug Interactions. WebMD. 2016-02-23 [2009-11-23]. （原始内容存档于2016-02-23）.
Public Health Advisory: Updated Safety Information about a drug interaction between Clopidogrel Bisulfate (marketed as Plavix) and Omeprazole (marketed as Prilosec and Prilosec OTC). Food and Drug Administration (FDA). 2009-11-17 [2010-03-13]. （原始内容存档于2009-12-29）.
Safety announcement: Reduced effectiveness of Plavix in patients who are poor metabolizers. U.S. Food and Drug Administration. 3 August 2017. （原始内容存档于2010-03-15）.
New products and markets fuel growth in 2005. IMS Health. [2009-03-02]. （原始内容存档于2008-06-03）.
Top Ten Global Products – 2007 (PDF). IMS Health. 26 February 2008 [2009-03-02]. （原始内容存档 (PDF)于2011-02-25）.
Details for Plavix. （原始内容存档于2014-08-14）.
Preliminary Injunction Against Apotex Upheld on Appeal (新闻稿). Bristol-Myers Squibb. 2006-12-08 [2010-03-14]. （原始内容存档于2014-04-14）.
FDA Gives Plavix a 6 Month Extension-Patent Now Expires on 17 May 2012. 26 January 2011 [2012-01-12]. （原始内容存档于2011-10-12）.
FDA approves generic versions of blood thinner Plavix (新闻稿). U.S. Food and Drug Administration (FDA). 2012-05-17. （原始内容存档于2016-03-11）.

webmd.com

DeNoon DJ. FDA Warns Plavix Patients of Drug Interactions. WebMD. 2016-02-23 [2009-11-23]. （原始内容存档于2016-02-23）.